Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jan 17:2020:5040521.
doi: 10.1155/2020/5040521. eCollection 2020.

Telemonitoring Interventions in COPD Patients: Overview of Systematic Reviews

Xuanlin Li  1   2   3 , Yang Xie  1   2   3 , Hulei Zhao  1   2   3 , Hailong Zhang  1   2   3 , Xueqing Yu  1   2   3 , Jiansheng Li  1   2   3
Affiliations
Review

Telemonitoring Interventions in COPD Patients: Overview of Systematic Reviews

Xuanlin Li et al. Biomed Res Int. .

Abstract

Objective: The role of telemonitoring interventions (TIs) for chronic obstructive pulmonary disease (COPD) has been studied in many systematic reviews (SRs) and meta-analyses (MAs), but robust conclusions have not been reached due to wide variations in scopes, qualities, and outcomes. The aim of this overview was to determine the effectiveness of TIs on COPD patients.

Methods: PubMed, EMBASE, Web of Science, and Cochrane Library were searched for all reviews on the topic of TI in treating COPD from inception to July 8, 2019, without restrictions on language. According to the inclusion and exclusion criteria, the retrieved literature studies were screened to select SRs and MAs of randomized control trials (RCTs) that evaluated the effects of TIs in COPD patients. The methodological quality of SRs and MAs was assessed with the AMSTAR-2 tool, and the strength of evidence was assessed with the grades of recommendations, assessment, development, and evaluation (GRADE) system for concerned outcomes in terms of mortality, quality of life (SGRQ total scores), exercise capacity (6MWD), and exacerbation-related outcomes (hospitalizations, exacerbation rate, and emergency room visits).

Results: Our overview included eight SRs and MAs published in 2011 to 2019, from 95 RCTs involving 10632 participants. After strict evaluation by the AMSTAR-2 tool, 75% of the SRs and MAs in this overview had either low or critically low methodological quality. The effects of TIs for COPD on mortality, quality of life, exercise capacity, and exacerbation-related outcomes are limited, and all of these outcomes scored either low or very low quality of evidence on the GRADE system.

Conclusions: There might be insufficient evidence to support the effectiveness of TIs for COPD currently, but the results of this overview should be interpreted dialectically and prudently, and the role of TIs in COPD needs further exploration.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflicts of interest.

Figures

Figure 1
Figure 1
Study selection process for this overview.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Global strategy for the diagnosis, management and prevention of COPD: global initiative for chronic obstructive lung disease (GOLD) 2019. http://goldcopd.org/wp-content/uploads/2018/11/GOLD-2019-v1. - PubMed
    1. Steel N., Ford J. A., Newton J. N., et al. Changes in health in the countries of the UK and 150 English local authority areas 1990-2016: a systematic analysis for the global burden of disease study 2016. The Lancet. 2018;392(10158):1647–1661. doi: 10.1016/s0140-6736(18)32207-4. - DOI - PMC - PubMed
    1. GBD 2017 Diet Collaborators. Health effects of dietary risks in 195 countries, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet. 2019;393(10184):1958–1972. doi: 10.1016/S0140-6736(19)30041-8. - DOI - PMC - PubMed
    1. Zhou M., Wang H., Zeng X., et al. Mortality, morbidity, and risk factors in China and its provinces, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet. 2019;394(10204):1145–1158. doi: 10.1016/s0140-6736(19)30427-1. - DOI - PMC - PubMed
    1. Wang C., Xu J., Yang L., et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study. The Lancet. 2018;391(10131):1706–1717. doi: 10.1016/s0140-6736(18)30841-9. - DOI - PubMed